Sari Pesonen

Company: Valo Therapeutics

Job title: Co-Founder & Chief Scientific Officer

Seminars:

PeptiCRAd – Flexible Peptide Delivery Platform for Therapeutic Cancer (Neoantigen) Vaccines 4:00 pm

• Reviewing how the safety and efficacy of these vaccine modalities remains unclear in certain cancer patients • Addressing the complex manufacturing process and regulatory aspects • Developing neoantigen vaccines based on peptides and viral adjuvantsRead more

day: Day One